Breast Cancer - All SharePosts Relating To "aromasin"

EXPERT

PJ Hamel

(Profile)

Author, breast cancer survivor

Our Expert | Been Through It

Get Widget | RSS

posted 06/04/2009, comments (25)

Gain vs. Pain: Is It Time To Switch Back To Tamoxifen?

Are you a postmenopausal survivor taking an aromatase inhibitor to prevent a recurrence?Whether you answer yes or no to the question above, keep reading. Because if you’re a breast cancer survivor taking hormonal therapy (as about 80% of us are), this post applies to you: either now, or in the future.If your breast cancer was... Read more Chevron

Read all my posts | Subscribe | Send Message

EXPERT

Angi

(Profile)

I've partnered with HC/MBCN to help with all your BC needs

Our Expert | Living With It

RSS

posted 01/08/2009, comments (0)

"Aromatase Inhibitors More Effective than Tamoxifen"

Here's an article that just gets me. The more I read stuff like this the less I beleive in statistics, studies, risks or numbers. From the San Antonio Breast Cancer Symposium - courtesy of CURE publication. "Aromatase Inhibitors More Effictive than Tamoxifen" "On the 1st day of the meeting, a morning seeion on adjuvant hormonal... Read more Chevron

Read all my posts | Subscribe | Send Message

EXPERT

PJ Hamel

(Profile)

Author, breast cancer survivor

Our Expert | Been Through It

Get Widget | RSS

posted 07/02/2008, comments (8)

Aromatase Inhibitor FAQs: Hormone Therapy (Arimidex, Femara, and Aromasin) for Breast Cancer

Q. I've been on tamoxifen for a couple of years, and now my doctor is switching me to an aromatase inhibitor. I understand how tamoxifen works, but this AI is a whole new thing... how does it work? A. Aromatase inhibitors (pronounced aroma-tase: just like it looks) come in three basic flavors: Femara® (letrozole), Arimidex®... Read more Chevron

Read all my posts | Subscribe | Send Message

EXPERT

PJ Hamel

(Profile)

Author, breast cancer survivor

Our Expert | Been Through It

Get Widget | RSS

posted 03/12/2008, comments (4)

Aromatase Inhibitors: Startling New Study Shows Dramatic Reduction in Recurrence Rates

If you finished taking tamoxifen for ER-receptive breast cancer even as long as 7 years ago, you might be able to do something right now to cut your risk for another bout of cancer by as much as 82%. The March 10 edition of the Journal of Clinical Oncology features results of a study that could impact millions of breast cancer... Read more Chevron

Read all my posts | Subscribe | Send Message